Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes

Am J Obstet Gynecol. 2001 Feb;184(3):368-73. doi: 10.1067/mob.2001.111796.

Abstract

Objective: We report our experience with a transvaginally applied intracervical fibrin sealant at <24 weeks' gestation.

Study design: This is an observational study of a referred patient population, with preterm premature rupture of the membranes at <24 weeks' gestation.

Results: Twelve women consented to our protocol. The mean gestational age at preterm premature rupture of membranes was 19 weeks 4 days (range, 13-23 weeks); the mean gestational age at treatment was 20 weeks 5 days (range, 17-23 weeks). All women had a diminution in the amount of amniotic fluid leakage with an increase in amniotic fluid index. Among the 12 pregnancies (13 fetuses), there were 7 surviving neonates. Two women had apparent "resealing" of the membranes.

Conclusion: Fibrin sealants in midtrimester rupture of the membranes may lead to improved outcomes and now warrant formal evaluation.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Amniotic Fluid / diagnostic imaging
  • Amniotic Fluid / physiology
  • Bed Rest
  • Cervix Uteri / pathology
  • Female
  • Fetal Membranes, Premature Rupture / complications
  • Fetal Membranes, Premature Rupture / therapy*
  • Fibrin Tissue Adhesive / administration & dosage
  • Fibrin Tissue Adhesive / therapeutic use*
  • Gestational Age
  • Humans
  • Oligohydramnios / complications
  • Pilot Projects
  • Pregnancy
  • Pregnancy Outcome
  • Ultrasonography

Substances

  • Fibrin Tissue Adhesive